Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute effects of dapagliflozin on hepatic metabolism
NCT02558270Phase 2Unknown
- Sponsor
- Medical University of Vienna
- Start
- Jun 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dapagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Medical University of Vienna. Status: unknown.
02
Drugs
dapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02558270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02558270.